Literature DB >> 34364402

CircCNIH4 inhibits gastric cancer progression via regulating DKK2 and FRZB expression and Wnt/β-catenin pathway.

Qi Shi1, Chuanwen Zhou1, Rui Xie1, Miaomiao Li1, Peng Shen1, Yining Lu1, Shijie Ma2.   

Abstract

BACKGROUND: Circular RNAs (circRNAs) have been reported to play an important role in tumor progression in various cancer types, including gastric cancer. The aim of this study was to investigate the role of circCNIH4 (hsa_circ_0000190) in gastric cancer and the underlying mechanism.
METHODS: The expression levels of circCNIH4 and Wnt antagonist genes were detected by quantitative real-time polymerase chain reaction (qRT-PCR). The protein levels of β-catenin, Ki67, Dickkopf 2 (DKK2) and Frizzled related protein (FRZB) were measured by western blot. Ectopic overexpression or knockdown of circCNIH4, proliferation, apoptosis, migration and invasion by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT), flow cytometry and transwell assay in vitro, and in vivo experiment, were employed to assess the role of circCNIH4 in gastric cancer.
RESULTS: CircCNIH4 was downregulated in gastric cancer tissues and cells. Overexpression of circCNIH4 inhibited gastric cancer cell proliferation, migration and invasion and promoted apoptosis by inactivating Wnt/β-catenin pathway in vitro. CircCNIH4 induced the expression of DKK2 and FRZB in gastric cancer cells. Moreover, silencing of DKK2 or FRZB reversed circCNIH4 overexpression-mediated effects on gastric cancer cells. Additionally, circCNIH4 suppressed tumor growth via regulating DKK2 and FRZB expression in gastric cancer in vivo.
CONCLUSION: Our study demonstrated that circCNIH4 played a tumor-inhibiting role through upregulating DKK2 and FRZB expression and suppressing Wnt/β-catenin pathway in gastric cancer, which might provide a potential biomarker for the diagnosis and treatment of gastric cancer.
© 2021. The Author(s).

Entities:  

Keywords:  CircCNIH4; DKK2; FRZB; Gastric cancer; Wnt/β-catenin pathway

Year:  2021        PMID: 34364402     DOI: 10.1186/s40709-021-00140-x

Source DB:  PubMed          Journal:  J Biol Res (Thessalon)        ISSN: 1790-045X            Impact factor:   1.889


  6 in total

1.  A novel circular RNA hsa_circ_0008035 contributes to gastric cancer tumorigenesis through targeting the miR-375/YBX1 axis.

Authors:  Shifang Huang; Xiaolin Zhang; Bingsheng Guan; Peng Sun; Chong Tsz Hong; Juzheng Peng; Shaohui Tang; Jingge Yang
Journal:  Am J Transl Res       Date:  2019-04-15       Impact factor: 4.060

2.  FRZB up-regulated in hepatocellular carcinoma bone metastasis.

Authors:  Jia Huang; Wenhao Hu; Xiangjin Lin; Xuanwei Wang; Ketao Jin
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  FRZB up-regulation is correlated with hepatic metastasis and poor prognosis in colon carcinoma patients with hepatic metastasis.

Authors:  Yanping Shen; Fang Zhang; Huanrong Lan; Ke Chen; Qi Zhang; Guoming Xie; Lisong Teng; Ketao Jin
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

Review 4.  Progress in the treatment of advanced gastric cancer.

Authors:  Zheyu Song; Yuanyu Wu; Jiebing Yang; Dingquan Yang; Xuedong Fang
Journal:  Tumour Biol       Date:  2017-07

Review 5.  Epidemiology of gastric cancer: global trends, risk factors and prevention.

Authors:  Prashanth Rawla; Adam Barsouk
Journal:  Prz Gastroenterol       Date:  2018-11-28

6.  DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

Authors:  Jianyu Yang; Yongsheng Jiang; Ruizhe He; Wei Liu; Minwei Yang; Lingye Tao; Xueliang Fu; Yang Shen; Jiao Li; Dejun Liu; Yanmiao Huo; Junfeng Zhang; Rong Hua; Zhigang Zhang; Yongwei Sun
Journal:  J Immunol Res       Date:  2019-09-08       Impact factor: 4.818

  6 in total
  1 in total

Review 1.  The functional roles of the circRNA/Wnt axis in cancer.

Authors:  Chen Xue; Ganglei Li; Qiuxian Zheng; Xinyu Gu; Zhengyi Bao; Juan Lu; Lanjuan Li
Journal:  Mol Cancer       Date:  2022-05-05       Impact factor: 41.444

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.